From: Integrated analysis of tumor-associated macrophages and M2 macrophages in CRC: unraveling molecular heterogeneity and developing a novel risk signature
Primer
Forward (5’ to 3’)
Reverse (5’ to 3’)
NAGK
CACTATTTCCAGGTGCCAG
GAAGATATAGCGGGAAAGGG
DAPK1
CATCAAGAACCGAGAAGGAG
CAATGTGTCCGTCCTTGTC
TRAF1
AAAGAGAACCCATCTGTCG
ATGAAGGTGACCTTGTTCC
GAPDH
TCAAGATCATCAGCAATGCC
CGATACCAAAGTTGTCATGGA